Literature DB >> 27825595

Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.

Timothy Lawes1, José-María Lopez-Lozano2, Cesar A Nebot3, Gillian Macartney4, Rashmi Subbarao-Sharma4, Karen D Wares5, Carolyn Sinclair5, Ian M Gould6.   

Abstract

BACKGROUND: Whereas many antibiotics increase risk of Clostridium difficile infection through dysbiosis, epidemic C difficile ribotypes characterised by multidrug resistance might depend on antibiotic selection pressures arising from population use of specific drugs. We examined the effect of a national antibiotic stewardship intervention limiting the use of 4C antibiotics (fluoroquinolones, clindamycin, co-amoxiclav, and cephalosporins) and other infection prevention and control strategies on the clinical and molecular epidemiology of C difficile infections in northeast Scotland.
METHODS: We did a non-linear time-series analysis and quasi-experimental study to explore ecological determinants of clinical burdens from C difficile infections and ribotype distributions in a health board serving 11% of the Scottish population. Study populations were adults (aged ≥16 years) registered with primary carer providers in the community (mean 455 508 inhabitants) or admitted to tertiary level, district general, or geriatric hospitals (mean 33 049 total admissions per month). A mixed persuasive-restrictive 4C antibiotic stewardship intervention was initiated in all populations on May 1, 2009. Other population-specific interventions considered included limiting indications for macrolide prescriptions, introduction of alcohol-based hand sanitiser, a national hand-hygiene campaign, national auditing and inspections of hospital environment cleanliness, and reminders to reduce inappropriate use of proton-pump inhibitors. The total effect of interventions was defined as the difference between observations and projected scenarios without intervention. Primary outcomes were prevalence density of C difficile infection per 1000 occupied bed-days in hospitals or per 100 000 inhabitant-days in the community.
FINDINGS: Between Jan 1, 1997, and Dec 31, 2012, we identified 4885 cases of hospital-onset C difficile infection among 1 289 929 admissions to study hospitals, and a further 1625 cases of community-onset C difficile infection among 455 508 adults registered in primary care. Use of 4C antibiotics was reduced by 50% in both hospitals (mean reduction 193 defined daily doses per 1000 occupied bed-days, 95% CI 45-328, p=0·008) and the community (1·85 defined daily doses per 1000 inhabitant-days, 95% CI 0·23-3·48, p=0·025) during antibiotic stewardship. Falling 4C use predicted rapid declines in multidrug-resistant ribotypes R001 and R027. Hospital-onset C difficile infection prevalence densities were associated with fluoroquinolone, third-generation cephalosporin, macrolides, and carbapenem use, exceeding hospital population specific total use thresholds. Community-onset C difficile infection prevalence density was predicted by recent hospital C difficile infection rates, introduction of mandatory surveillance in individuals older than 65 years, and primary-case use of fluoroquinolones and clindamycin exceeding total use thresholds. Compared with predictions without intervention, C difficile infection prevalence density fell by 68% (mean reduction 1·01 per 1000 occupied bed-days, 0·27-1·76, p=0·008) in hospitals and 45% (0·083, 0·045-0·121 cases per 100 000 inhabitant-days, p<0·0001) in the community, during antibiotic stewardship. We identified no significant effects from other interventions.
INTERPRETATION: Limiting population use of 4C antibiotics reduced selective pressures favouring multidrug-resistant epidemic ribotypes and was associated with substantial declines in total C difficile infections in northeast Scotland. Efforts to control C difficile through antibiotic stewardship should account for ribotype distributions and non-linear effects. FUNDING: NHS Grampian Microbiology Endowment Fund.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27825595     DOI: 10.1016/S1473-3099(16)30397-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  27 in total

1.  A Propensity Score Matched Study of the Positive Impact of Infectious Diseases Consultation on Antimicrobial Appropriateness in Hospitalized Patients with Antimicrobial Stewardship Oversight.

Authors:  Jacqueline T Bork; Kimberly C Claeys; Emily L Heil; Mary Banoub; Surbhi Leekha; John D Sorkin; Michael Kleinberg
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

Review 2.  Fluoroquinolone Restriction as an Effective Antimicrobial Stewardship Intervention.

Authors:  Kimberly C Claeys; Teri L Hopkins; Ana D Vega; Emily L Heil
Journal:  Curr Infect Dis Rep       Date:  2018-03-23       Impact factor: 3.725

3.  Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.

Authors:  Brandon J Webb; Aruna Subramanian; Bert Lopansri; Bruce Goodman; Peter Bjorn Jones; Jeffrey Ferraro; Edward Stenehjem; Samuel M Brown
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

4.  Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011-2015.

Authors:  Alice Y Guh; Yi Mu; James Baggs; Lisa G Winston; Wendy Bamberg; Carol Lyons; Monica M Farley; Lucy E Wilson; Stacy M Holzbauer; Erin C Phipps; Zintars G Beldavs; Marion A Kainer; Maria Karlsson; Dale N Gerding; Ghinwa Dumyati
Journal:  Am J Infect Control       Date:  2018-01-09       Impact factor: 2.918

Review 5.  Treatment of Clostridioides (Clostridium) difficile infection.

Authors:  Jarmo Oksi; Veli-Jukka Anttila; Eero Mattila
Journal:  Ann Med       Date:  2019-12-13       Impact factor: 4.709

6.  Identifying Targets for Antibiotic Use for the Management of Carbapenem-Resistant Acinetobacter baumannii (CRAb) in Hospitals-A Multi-Centre Nonlinear Time-Series Study.

Authors:  Zainab Said Al-Hashimy; Barbara R Conway; Mubarak Al-Yaqoobi; Faryal Khamis; Ghalib Zahran Al Mawali; Aisha Mahad Al Maashani; Yaqoob Said Al Hadhrami; Said Salim Al Alawi; Mohammed Said Al Mamari; William J Lattyak; Elizabeth A Lattyak; Motasem Aldiab; Ian Gould; José-María López-Lozano; Mamoon A Aldeyab
Journal:  Antibiotics (Basel)       Date:  2022-06-07

Review 7.  Mechanisms and impact of antimicrobial resistance in Clostridioides difficile.

Authors:  Chetna Dureja; Abiola O Olaitan; Julian G Hurdle
Journal:  Curr Opin Microbiol       Date:  2022-01-22       Impact factor: 7.584

8.  An evaluation of toxigenic Clostridioides difficile positivity as a patient outcome metric of antimicrobial stewardship in Saudi Arabia.

Authors:  Christopher A Okeahialam; Ali A Rabaan; Albert Bolhuis
Journal:  J Infect Prev       Date:  2021-06-22

9.  A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance.

Authors:  José-María López-Lozano; Timothy Lawes; César Nebot; Arielle Beyaert; Xavier Bertrand; Didier Hocquet; Mamoon Aldeyab; Michael Scott; Geraldine Conlon-Bingham; David Farren; Gábor Kardos; Adina Fésűs; Jesús Rodríguez-Baño; Pilar Retamar; Nieves Gonzalo-Jiménez; Ian M Gould
Journal:  Nat Microbiol       Date:  2019-04-08       Impact factor: 17.745

Review 10.  Clostridium difficile: Diagnosis and the Consequence of Over Diagnosis.

Authors:  Helen S Lee; Kamryn Plechot; Shruti Gohil; Jennifer Le
Journal:  Infect Dis Ther       Date:  2021-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.